111 (YI) Stock Price, News & Analysis

Company Overview

111, Inc. (NASDAQ:YI) operates as a leading online pharmaceutical and healthcare services platform in China. Through its proprietary e-commerce portal and mobile applications, the company offers a broad range of prescription and over-the-counter medications, healthcare products, medical devices, and nutritional supplements. Its digital infrastructure integrates telemedicine consultations, electronic prescriptions, and real-time order tracking, enabling patients to receive timely access to essential treatments without visiting physical pharmacies.

At the core of 111’s business model is an omnichannel distribution network that combines online ordering with a network of partner warehouses and affiliated retail pharmacies. This hybrid approach allows the company to fulfill orders across China’s major urban centers and more remote regions, ensuring same-day or next-day delivery for many customers. In addition to pharmaceutical sales, 111 offers value-added services such as chronic disease management programs, medication adherence reminders, and personalized health education content designed to support long-term patient outcomes.

Founded in the early 2010s and headquartered in Shanghai, 111 has grown rapidly by leveraging China’s digital transformation in healthcare. The company has continually invested in data analytics and artificial intelligence to optimize inventory management, tailor marketing to consumer needs, and enhance its telehealth consultation capabilities. Its platform also integrates with third-party health insurance and payment providers, simplifying reimbursement processes for users and expanding its reach among both urban professionals and elderly patients.

111 is led by a management team with extensive experience in pharmaceuticals, e-commerce, and healthcare technology. Under their guidance, the company has forged strategic partnerships with domestic hospitals, healthcare institutions, and logistics providers. As regulatory frameworks evolve in China’s online pharmacy sector, 111 is well positioned to capitalize on increased consumer adoption of digital health services and continued government support for Internet-based medical innovations.

Key Stats

• Today's Range: $7.48 to $7.57
• 50-Day Range: $6.93 to $8.36
• 52-Week Range: $4.15 to $12.60
• Volume: 1,592 shs
• Average Volume: 24,821 shs
• Market Capitalization: $64.80 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

111 Stock Analysis - MarketRank™

111 scored higher than 4% of companies evaluated by MarketBeat, and ranked 873rd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for 111.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of 111 is -11.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of 111 is -11.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

1.27% of the float of 111 has been sold short.

Short Interest Ratio / Days to Cover

111 has a short interest ratio ("days to cover") of 5.1.

Change versus previous month

Short interest in 111 has recently increased by 11,577.78%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

111 does not currently pay a dividend.

Dividend Growth

111 does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.27% of the float of 111 has been sold short.

Short Interest Ratio / Days to Cover

111 has a short interest ratio ("days to cover") of 5.1.

Change versus previous month

Short interest in 111 has recently increased by 11,577.78%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.0 / 5
• News Sentiment: -0.17

News Sentiment

111 has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.00 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for 111 this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, 111 insiders have not sold or bought any company stock.

Percentage Held by Insiders

43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 21.32% of the stock of 111 is held by institutions.

YI Stock Analysis - Frequently Asked Questions

How have YI shares performed this year?

111's stock was trading at $6.23 at the beginning of 2025. Since then, YI shares have increased by 20.4% and is now trading at $7.50.

How were 111's earnings last quarter?

111, Inc. Sponsored ADR (NASDAQ:YI) posted its quarterly earnings data on Thursday, June, 19th. The company reported ($0.20) EPS for the quarter. The firm had revenue of $486.35 million for the quarter.

When did 111's stock split?

111 shares reverse split on the morning of Friday, January 24th 2025.The 1-10 reverse split was announced on Wednesday, January 8th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 23rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

When did 111 IPO?

111 (YI) raised $140 million in an initial public offering on Wednesday, September 12th 2018. The company issued 9,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Citigroup and CICC acted as the underwriters for the IPO.

How do I buy shares of 111?

Shares of YI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of 111 own?

Based on aggregate information from My MarketBeat watchlists, some other companies that 111 investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Innovative Industrial Properties (IIPR), Magnite (MGNI), Roku (ROKU), Twilio (TWLO).

Company Calendar

• Last Earnings: 6/19/2025
• Today: 7/11/2025
• Next Earnings (Estimated): 8/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Retail
• Current Symbol: NASDAQ:YI
• CIK: 1738906
• Web: www.111.com.cn
• Phone: 862120536666
• Fax: N/A
• Employees: 1,238
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.64)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.42 million
• Net Margins: -0.48%
• Pretax Margin: -0.17%
• Return on Equity: N/A
• Return on Assets: -2.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.14
• Quick Ratio: 0.53

Sales & Book Value

• Annual Sales: $1.97 billion
• Price / Sales: 0.03
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($10.43) per share
• Price / Book: -0.72

Miscellaneous

• Outstanding Shares: 8,640,000
• Free Float: 4,849,000
• Market Cap: $64.80 million
• Optionable: Optionable
• Beta: 0.44